KRAS and cancer: Indeed, KRAS-mutant mouse and human cancer cell lines displayed markedly increased baseline Il1r1/IL1R1 mRNA expression compared with WT cell lines, and significantly downregulated Il1r1/IL1R1 transcript levels after deltarasin treatment (Figure 6b, upper panel).